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The impact of body mass index (BMI) and body weight on hospitalization rates in haemodial-
ysis patients is unknown.
This study hypothesizes that being either underweight or obese is associated with a higher
hospitalization rate.
Observational study of 6296 European haemodialysis patients with prospective data col-
lection and follow-up every six months for three years (COSMOS study). The risk of being
hospitalized was estimated by a time-dependent Cox regression model and the annual riskBody mass index
Weight changes
Hospitalization risk
Nutritional markers
(incidence rate ratios, IRR) by Poisson regression. We  considered weight loss, weight gain
and  stable weight. Weight change analyses were also performed after patient stratiﬁcation
according to their baseline BMI.
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A total of 3096 patients were hospitalized at least once with 9731 hospitalizations in total.
The  hospitalization incidence (fully adjusted IRR 1.28, 95% CI [1.18–1.39]) was higher among
underweight patients (BMI <20 kg/m2) than patients of normal weight (BMI 20–25 kg/m2),
while the incidence of overweight (0.88 [0.83–0.93]) and obese patients (≥30 kg/m2, 0.85
[0.79–0.92]) was lower. Weight gain was associated with a reduced risk of hospitalization.
Conversely, weight loss was associated with a higher hospitalization rate, particularly in
underweight patients (IRR 2.85 [2.33–3.47]).
Underweight haemodialysis patients were at increased risk of hospitalization, while over-
weight and obese patients were less likely to be hospitalized. Short-term weight loss in
underweight individuals was associated with a strikingly high hospitalization rate.
©  2018 Sociedad Espan˜ola de Nefrologı´a. Published by Elsevier Espan˜a, S.L.U. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
Riesgo  de  hospitalización  asociado  con  el  índice  de  masa  corporal  y  los
cambios  de  peso  entre  los  pacientes  de  hemodiálisis  prevalentes
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Marcadores nutricionales
r  e  s  u  m  e  n
El impacto del índice de masa corporal (IMC) y el peso corporal sobre las tasas de hospital-
ización en pacientes en hemodiálisis es desconocido.
La  hipótesis del estudio es que tanto el bajo peso como la obesidad se asocian con un
exceso de hospitalizaciones.
Estudio observacional que incluye 6.296 pacientes europeos de hemodiálisis con recolec-
ción  prospectiva de datos y seguimiento cada 6 meses durante 3 an˜os (estudio COSMOS). El
riesgo de tener una hospitalización se estimó mediante regresión de Cox dependiente del
tiempo y el riesgo anual (razón de tasa de incidencia [IRR]) mediante regresión de Poisson. Se
consideró la pérdida de peso, el aumento de peso y el peso estable. Los análisis de cambios
de  peso también se realizaron después de la estratiﬁcación del paciente, de acuerdo con su
IMC inicial.
Tres mil noventa y seis pacientes fueron hospitalizados al menos una vez con un total de
9.731  hospitalizaciones. Los pacientes con bajo peso (IMC < 20 kg/m2) tuvieron una mayor
incidencia de hospitalización (IRR completamente ajustada 1,28, IC 95% [1,18-1,39]) que los
pacientes con peso normal (IMC 20-25 kg/m2), mientras que aquellos con sobrepeso (0,88
[0,83-0,93]) y obesos (≥ 30 kg/m2, 0,85 [0,79-0,92]) tuvieron una incidencia menor. El aumento
de  peso se asoció con menor riesgo de hospitalización. Por el contrario, la pérdida de peso
se  asoció con una mayor incidencia de hospitalización especialmente en pacientes con bajo
peso  (IRR 2,85 [2,33-3,47]).
Los pacientes con hemodiálisis con bajo peso tienen un mayor riesgo de hospitalización,
mientras que el sobrepeso y la obesidad tuvieron menos probabilidades de ser hospitaliza-
dos. Las pérdidas de peso a corto plazo en individuos con bajo peso se asociaron a una tasa
de  hospitalización notablemente alta.
©  2018 Sociedad Espan˜ola de Nefrologı´a. Publicado por Elsevier Espan˜a, S.L.U. Este es un
artı´culo Open Access bajo la licencia CC BY-NC-ND (http://creativecommons.org/licenses/
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he relationship between protein energy wasting (PEW) and
ortality in patients undergoing maintenance haemodialysis
HD) therapy is well documented.1,2 Paradoxical associations
etween various nutritional markers such as body mass index
BMI) and weight changes with mortality risk in HD patients
ave been described, showing better outcomes for those sub-
ects with a higher BMI  or that gain weight over time.3–7
While hospitalization is an inherently limited outcome
easure in etiological and prognostic research, it is aby-nc-nd/4.0/).
fundamental outcome for health-economy research and for
research on the quality of clinical care. The risk of hospitaliza-
tion increases in a graded manner by progressive CKD stage8
and, for dialysis patients, it has been estimated to account
for 40–60% of total healthcare expenditures.9,10 During the
ﬁrst year on dialysis, 77% of patients require hospitalization
and spend 8.6% of patient treatment days in hospital.11 Given
the mounting epidemics of obesity and the parallel decline
12in underweight and malnutrition in the dialysis population,
identiﬁcation of potentially modiﬁable hospitalization risk
factors is important to improve the quality of clinical care
in this population. Both malnutrition13,14 and obesity15–17 are
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important causes of hospitalization in the community, with
considerable economic and social cost implications, partic-
ularly for inpatient care.18 Data concerning the association
between nutritional parameters and hospitalization risk in
HD patients are, however, scarce and mainly focused on the
study of albumin levels.11,19–22 We here address the associa-
tion between BMI  and short-term body weight changes with
the hospitalization risk of dialysis patients. Given the parallel
risk for hospitalization of extreme nutritional categories, we
hypothesize that both obesity and underweight associate with
higher hospitalization rates.
Methods
Study  population
The Current Management of Secondary Hyperparathyroidism:
A Multicentre Observational Study (COSMOS) is a multicentre,
prospective and open cohort study with 3 years of follow-
up including patients undergoing maintenance haemodialysis
from 227 facilities in 20 European countries. The original aim
of the cohort was to survey mineral and bone disturbances
and related clinical practice patterns. Patients and facilities
were randomly selected among a complete list of hospital and
satellite dialysis centres from the 20 participating countries.
The number of patients recruited in each country was propor-
tional to its dialysis population, and each centre was expected
to recruit 20 patients. COSMOS initially recruited 4500 patients
and followed them up with data collections every six months
for up to three years. Subject dying or leaving the study
for other reasons (renal transplantation, change to a non-
COSMOS facility or switch to peritoneal dialysis) during that
period were replaced by 2297 new patients on haemodialy-
sis for less than 1 year, totalling 6797. Recruitment took place
between February 2005 and July 2007, and follow-up ended in
July 2010. Study design and ethical approval, as well as ran-
dom recruitment characteristics have been described in detail
elsewhere.23,24
Demographic,  clinical,  and  laboratory  data
Data on age, sex, height, post-HD weight, smoking (never,
former or current smoker), diabetes mellitus, primary kid-
ney disease, cardiovascular disease, country, type of facility
(public or private) and haemodialysis-related variables (vin-
tage, modality and hours per week) were collected when
the patients entered the study. Data on weight, haemodial-
ysis modality, and hours per week were collected every 6
months during the 3-year observation period. According to
protocol design, weight was measured immediately after the
haemodialysis session.
Hospitalization  dataDuring the 3-year observation of the cohort, all occurring
hospitalization events were registered for each patient every
6 months. Time to ﬁrst hospitalization was collected and
annual incidence rate were also calculated and used in the3  8(5):520–527
analyses evaluating the association between BMI, weight
changes and the hospitalization risk.
Statistical  design  and  analysis
Categorical variables are presented as percentage and con-
tinuous variables as mean ± SD or median (interquartile
range), where appropriate. BMI was calculated as weight in
kilograms divided by the square of height in meters. BMI
was analyzed after stratiﬁcation by 4 categories. Accord-
ing to the World Health Organization (WHO) guidelines,
obesity was deﬁned as a BMI ≥30 kg/m2, and overweight
was deﬁned as a BMI of 25–29 kg/m2. We deﬁned normal
weight as a BMI of 20–24 kg/m2, which is within the nor-
mal  range according to the WHO,  and underweight as a
BMI  <20 kg/m2. Normal weight was used, a priori, as the
reference category. Weight changes over a 6-month period
were calculated according to the difference between consec-
utive weight values, expressed as a percentage. Categorical
analysis of weight change was established along previous
analyses of BMI we performed in COSMOS6 and 3 cate-
gories were identiﬁed weight loss (decreases >1%), weight
gain (increases >1%) and stable weight (weight changes of
less than ±1%). We chose this deﬁnition to allow compari-
son with preceding studies,6,25 where mortality associations
were already observed for such small weight variations. Sta-
ble weight (within 1% variation) was considered the reference
category.
In the analysis of hospitalization risks, both time-to-event
analysis and incidence rates are clinically important and com-
plementary outcomes. We performed time-dependent Cox
proportional hazards regressions to assess the associations
between 6-month BMI or weight changes and the risk to
have one hospitalization. In these analyses patients were
censored if undergoing renal transplantation (n = 382), death
(n = 332), lost to follow-up (transfer to a non-COSMOS facil-
ity) (n = 136), change to peritoneal dialysis (n = 5) or end of
the study, whichever occurred ﬁrst. Data is presented as
hazard ratios (HR) and 95% conﬁdence intervals (CI). In addi-
tion, we  used Poisson regression models to estimate the
association between BMI or weight changes and the annual
hospitalization rate versus the referent category, thus pre-
senting data as incidence rate ratios (IRR) and 95% CI. In
these analyses, we used either the baseline BMI  or weight
changes during the ﬁrst 6 months of follow-up, and took
into account all hospitalizations registered for each patient
to estimate annual incidence rates. To both approaches, mul-
tivariate adjustment controlled for confounders including
age, sex, smoking, country, type of haemodialysis centre,
dialysis vintage, haemodialysis hours per week and modal-
ity. Covariates were considered as time-dependent when
applicable, except sex, smoking, diabetes mellitus, cardio-
vascular disease, country, type of haemodialysis centre and
primary kidney disease. Statistical signiﬁcance was set at
the level of P < 0.05. All statistical analyses were performed
using STATA version 12.1 (Stata Corporation College Station,
TX).
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Table 1 – Patient characteristics according to basal body mass index categories.
All patients <20 kg/m2 20–24 kg/m2 25–29 kg/m2 ≥30 kg/m2
(n = 6296) (n = 690) (n = 2664) (n = 1955) (n = 987)
Rates of hospitalization (admissions/100 person-years) 105 (0, 133) 111 (0, 157) 105 (0, 133) 99 (0, 133) 110 (0, 137)
Age (yr) 64  ± 14 61 ± 18 64 ± 15 65 ± 13 63 ± 12
Men (%) 61 47 64 65 53
Body mass index (kg/m2) 25.3 ± 4.9 18.4 ± 1.3 22.6 ± 1.4 27.1 ± 1.4 33.8 ± 3.8
Diabetes mellitus (%) 31 15 24 35 53
Cardiovascular disease (%) 72 67 71 74 74
Smoking (%)
Current 17 24 18 15 11
Former 19 11 20 20 20
Never 64 65 62 65 69
Primary kidney disease (%)
Hypertension 20 21 19 23 17
Glomerulonephritis 17 24 20 14 12
Polycystic kidney disease 8 8 9 8 7
Diabetes mellitus 21 9 17 24 36
Obstructive/interstitial 12 12 12 11 11
Tumours 2 2 2 1 2
Unknown 12 13 12 12 9
Other 8 11 9 7 6
Vintage (months) 20 (8–51) 26 (8–67) 22 (8–57) 19 (8–47) 16 (7–40)
Haemodialysis modality (%)
Conventional low-ﬂux 54 59 54 54 51
Conventional high-ﬂux 37 33 37 37 39
Other 9 7 9 9 10
Haemodialysis hours per week (%)
<12 21 28 22 20 15
12 55 56 57 55 51
>12 24 16 21 25 34
Categorical data are shown as percentage; continuous data as mean ± SD, except for vintage that is shown as median and interquartile range
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Table 2 – Time-dependent associations (every 6 months)
between body mass index (BMI) and time to
hospitalization in 6296 haemodialysis from COSMOS
stratiﬁed by BMI  categories.
Unadjusted Adjusted
BMI <20 kg/m2 1.20 (1.09–1.33) 1.22 (1.10–1.35)
BMI 20–24 kg/m2 1 1
BMI 25–29 kg/m2 0.93 (0.86–1.01) 0.89 (0.82–0.96)
BMI ≥30 kg/m2 0.98 (0.89–1.08) 0.93 (0.84–1.02)
Represented are unadjusted and adjusted hazard ratios and 95%
conﬁdence intervals for the risk of one hospitalization using
time-dependent Cox regression analyses. Adjusted model includes
multivariate adjustment for age, sex, smoking (never, former or cur-(25th and 75th percentiles).
Values in parentheses are the 25th and 75th percentiles.
esults
he present analysis included 6296 patients from COSMOS
ohort, after excluding 485 patients (7.1%) who did not have
ollow-up data and 16 patients further lacking information
n BMI. The majority of patients (94.5%) had undergone
aemodialysis for more  than 3 months. Baseline patient char-
cteristics at study entry and incidence rates of hospitalization
ccording to four BMI  categories are displayed in Table 1 and
ublished earlier.6 Both underweight and obese patients had
imilar incidence rates of hospitalization and higher than nor-
al  and overweight patients.
MI  and  the  risk  of  hospitalization
uring the 3-year follow-up, 3696 patients were hospital-
zed at least once, and a total of 9731 hospitalizations were
egistered in the cohort. The analysis of hazards to a ﬁrst hos-
italization considered a total of 17,797 observations through
ime-dependent analyses (Table 2). Underweight patients had
 higher risk of hospitalization than patients with normal
eight, while overweight and obese patients presented a
on-statistically signiﬁcant lower risk (model 2, Table 2).
n the analysis of annual incidence rates, the association
etween baseline BMI  and IRRs showed similar results (Fig. 1);rent), country, type of centre (public or private), dialysis vintage,
haemodialysis hours per week and modality.
correction for potential confounding factors increased
the IRRs estimates associated with underweight while it
decreased IRRs estimates of overweight and obese patients.
Weight  changes  and  the  risk  of  hospitalizationPatients experiencing weight losses within a 6-month period
were at higher risk of hospitalization than patients with sta-
ble weight. No association was seen in patients gaining weight
524  n e f r o l o g i a 2 0 1 8;
IRR (95% CI)
1.6
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BMI (kg/m2)
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Model 1
Model 2
Fig. 1 – Associations between baseline body mass index
(BMI) and annual hospitalization rates, expressed as
incidence rate ratios, in 6296 haemodialysis patients from
COSMOS. Normo weight individuals were taken as the
reference. Model 1 includes multivariate adjustment for
age, sex, smoking (never, former or current), country, type
of centre (public or private), dialysis vintage, haemodialysis
hours per week and modality; Model 2 includes
multivariate adjustment of variables included in model 1
plus primary kidney disease, diabetes mellitus and history
of cardiovascular disease.
Independently of baseline nutritional status, intercurrent(Table 3). When patients were stratiﬁed by their initial BMI,
the risks estimates associated with weight losses were statis-
tically signiﬁcant and similar in magnitude across categories,
with HR ranging from 1.88 and 2.04 (Fig. 2).
Patients experiencing weight losses during the ﬁrst
6 months of follow-up had higher annual hospitalization
rates (IRR) than individuals with stable body weight. Likewise,
patients gaining weight had signiﬁcantly lower hospitaliza-
tion rates (Table 3). When analyses were stratiﬁed by initial
BMI  categories, the magnitude of the association between dry
weight losses and the hospitalization rates was similar among
obese (IRR 1.41 [95% CI 1.22–1.62]), overweight (1.32 [1.19–1.47])
and normal weight (1.60 [1.46–1.75]) patients. However, a much
Table 3 – Associations between weight changes, time to ﬁrst ho
haemodialysis patients from COSMOS.
Time to hospitalization (hazard ratios) 
Unadjusted Adjusted 
Weight loss 2.10 (1.94–2.26) 2.05 (1.90–2.21) 
Stable weight 1 1 
Weight gain 1.09 (0.99–1.19) 1.07 (0.97–1.17) 
Represented are unadjusted and adjusted hazard ratios and 95% conﬁden
Cox regression analyses (every 6 months), and incidence rate ratios and 95
using Poisson regression analyses. Weight changes are considered as weigh
weight higher than 1%) and stable weight (weight changes of ±1%), taken h
adjustment for age, sex, smoking (never, former or current), country, type
per week and modality.3  8(5):520–527
higher risk was observed for underweight patients losing
weight, with an IRR of 2.85 [2.33–3.47]) (Figure 2).
Discussion
Compared with other chronic illnesses, patients with CKD
have more  comorbidities, the highest annual number of
inpatient stays, and the greatest number of hospital days.26
Heart failure and ischaemic heart disease have been sug-
gested as the top causes of hospitalization in this patient
population.8,11 Poor nutritional status, as identiﬁed by
hypoalbuminemia11,19–22 may also contribute to explain
such risk. To the best of our knowledge, this is the ﬁrst
study addressing the hospitalization risks associated with
BMI  and short-term body weight changes in this patient
population.
Contrary to our working hypothesis which, along with mor-
tality data,6 envisaged an U-shaped relationship between the
BMI  and the risk of hospitalization, in COSMOS we  found
that BMI is inversely associated with the risk of hospitaliza-
tion. Overweight and obese individuals were less likely to be
hospitalized and presented a lower annual incidence rate of
hospitalizations than normal weight patients. On the other
hand, underweight individuals presented a higher relative
risk of hospitalization. Even though a precious instrument to
investigate the effect of nutritional status in epidemiological
studies, BMI  is an imperfect marker of fat mass excess both at a
general population level27 and in the dialysis population.28–30
High BMI in part reﬂects high muscle mass, a body component
which is of fundamental importance for determining disabil-
ity in chronic diseases.31,32 Thus our analysis likely reﬂects
the importance of frailty and sarcopenia in engendering clin-
ical complications eventually leading to hospitalization in
long-term dialysis.33,34 Some observational in our analysis
may align with that hypothesis, such as the shorter dial-
ysis vintage across higher BMI  categories. In recent years,
it has become apparent however that muscle quality and
strength may be as important (or maybe more)  as muscle
mass.35,36diseases leading to hospitalization have a relevant impact
upon protein-energy metabolism in muscle mass. Accord-
ingly, we  found that short-term body weight losses have a
spitalization and risk of hospitalization per year in 6296
Annual hospitalization rates (incidence rate ratios)
Unadjusted Adjusted
1.61 (1.52–1.71) 1.52 (1.44–1.61)
1 1
0.99 (0.93–1.05) 0.90 (0.84–0.96)
ce intervals for the risk of one hospitalization using time-dependent
% conﬁdence intervals for calculation of annual hospitalization rates
t loss (decreases in weight higher that 1%), weight gain (increases in
ere as the reference category. Adjusted model includes multivariate
 of centre (public or private), dialysis vintage, haemodialysis hours
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kg/m2
≥30
≥30
Time to first hospitalization Incidence rate of hospitalization
25-29
25-29
20-24
20-24
<20
<20
All patients
All patients
Weight
gain
Weight
loss
0.0 0.0 0.5 0.51.0 1.01.5 1.5 2.0 2.02.5 2.53.0 3.03.5 3.5
HR (95% CI) IRR (95% CI)
Fig. 2 – Fully adjusted hazard ratios for the time to hospitalization (hazard ratios) and annual hospitalization rates
(incidence rate ratios) according to 6-month weight changes and stratiﬁed by body mass index (BMI) categories. Multivariate
adjustment controlled for age, sex, smoking (never, former or current), country, type of centre (public or private), dialysis
vintage, haemodialysis hours per week and modality primary kidney disease, diabetes mellitus and history of
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lear-cut relationship with the risk of hospitalization, increas-
ng it by two fold. In addition, in the long term, weight losses
ssociated with approximately 50% higher annual hospital-
zation rates than those maintaining a stable body weight
ver time, in line with the hypothesis that sarcopenia and
ntercurrent PEW may underlie the excess risk for hospital-
zation in dialysis patients. Although it is possible that short
erm BMI  changes in dialysis patients may in part reﬂect sub-
linical volume expansion,37 BMI  increases had just a minor,
on-signiﬁcant effect on the risk of hospitalization.
Our ﬁndings need to be interpreted considering several
trengths and limitations. Strengths include the prospective
nd careful cohort design (including their random recruit-
ent), the completeness of data and the record of consecutive
ospitalizations to allow the analysis of annual incidence
ates. Its large sample size and representativeness of the Euro-
ean HD population should also be remarked. As discussed,
MI  does feature several weaknesses as a metric of body fat in
KD patients.38,39 We  lack information on length of hospital
tay, which would have allowed us to make cost-effectiveness
nalysis, and we  have unsatisfactory collection on hospi-
alization causes which limits our capacity to deﬁne them.
 sensitivity analysis grouping countries according to global
ackground hospitalization rates would have been preferred
ut was not feasible. In addition, we  lack information on the
ntentionality of these body weight gains or losses. Given
he short time frame studied (6-month periods) and the
bsence of consensus guidelines on weight loss programs for
ialysis patients, we  are assuming them to be unintentional.
ther limitations are the ancillary nature of our ﬁndings,
s well as the lack of information on additional surrogates
f muscle and fat stores.40 As in all observational cohortstudies, residual confounding by unmeasured or unknown
confounders may have played a role. The predominantly
prevalent nature of the HD patients included in COSMOS
makes it vulnerable to survivor bias despite the careful adjust-
ment for dialysis vintage.
We  conclude that both underweight (lower than 20 kg/m2
in this analysis) and short-term body weight losses asso-
ciate with increased hospitalizations rates, likely because
it signals an unstable clinical situation including, but not
limited to, an unfavourable nutritional status. This, and our
previous report on hard endpoints,6 altogether emphasize
the importance of nutritional status on HD outcomes and
bring special attention to the importance of the short-term
weight losses in the underweight patients, a ﬁnding that
deserves additional surveillance. The high and rising health
cost absorbed by the dialysis population is a reason of concern
for health authorities and providers. Since hospitalization has
a major share in this cost, understanding the implication of
nutritional disorders for this outcome may help to set strate-
gies aimed at limiting hospital admission in this population.
Cost-effectiveness studies indicate that, along with improved
wellbeing, substantial savings in health costs can be obtained
by protein and energy supplementation in treatment or pre-
vention of malnutrition in the general population.41 Analyses
modelling the effect of such intervention on hospitalization
in the dialysis population suggest that the potential sav-
ings in hospitalization, treatment costs and mortality may
be substantial.42,43 Our observations provide further strength
to the quest of performing clinical trials aimed at assessing
whether nutritional interventions targeting body weight may
improve clinical outcomes and reduce hospitalization in this
high risk population.
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